Evaluation of treatments that modify the progression of COPD have been limited by the requirement for large numbers of participants and long follow-up intervals to establish efficacy. The traditional outcomes to document progression of COPD have been decline of lung function or mortality. Animal models of emphysema and COPD have been useful to dissect pathwaysfor COPD pathogenesis, but have not been developed as platforms for testing potential disease-modifying agents. In this project, we plan to test two promising treatments that may modify the progression of COPD: azithromycin, an immunomodulatory macrolide antibiotic, and losartan, an angiotensin receptor blocker. Preliminary evidence in humans and animals shows that these two drugs are effective in blocking pathways important in the progression of COPD. W plan to conduct a three-group placebo-controlled proof-of-concept clinical trial in 180 people with COPD assigned to azithromycin 250 mg thrice weekly., losartan 50 mg daily, or placebo. The primary outcome measures are indicators of anatomic lung remodeling ?quantitative measures of emphysema and airway wall dimensions by HRCT. Secondary outcomes will be a panel of biomarkers of systemic and respiratory inflammation and oxidative stress. Clinically relevant outcomes will include lung function and respiratory symptoms. Novel outcomes include measurement of airspace dimension using hyperpolarized helium MR imaging, and measures of innate immune responsivity of alveolar lavage cells. Concurrently, we will test these treatments using parallel outcomes in two strains of susceptible cigarette-smoke exposed mice to further understand which molecular pathways are involved. In particular, we will focus on the role of TGF-beta as a central regulator of lung remodeling in smoke-exposed mice. Measurements of disease progression will be made by histologic morphometry and hyper-polarized helium MRI. Other outcome measures include lung and systemic activity of cytokines, chemokines, growth factors, indicators of oxidative stress and apoptosis. Studies will be done to determine if these candidate drugs are effective in reducing progression of disease if given concurrently with smoking, or are effective after smoking injury has occurred and exposure has ceased.. The overall goal of this project is to provide information on the validity, reliability, and utility of intermediate endpoints and biomarkers in COPD clinical research and the value of animal models for testing treatments that can modify the progression of COPD.
| Robert, H Brown; Robert, A Wise; Kirk, Gregory et al. (2015) Lung density changes with growth and inflation. Chest 148:995-1002 |
| Shin, Mi-Kyung; Yao, Qiaoling; Jun, Jonathan C et al. (2014) Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia. J Appl Physiol (1985) 117:765-76 |
| Sussan, Thomas E; Ingole, Vijendra; Kim, Jung-Hyun et al. (2014) Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol 50:538-48 |
| McGrath-Morrow, Sharon A; Lauer, Thomas; Collaco, Joseph M et al. (2014) Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. Cytokine 65:4-9 |
| Mundel, Toby; Feng, Sheng; Tatkov, Stanislav et al. (2013) Mechanisms of nasal high flow on ventilation during wakefulness and sleep. J Appl Physiol (1985) 114:1058-65 |
| Yao, Qiaoling; Shin, Mi-Kyung; Jun, Jonathan C et al. (2013) Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res 54:1058-65 |
| Aggarwal, Neil R; D'Alessio, Franco R; Eto, Yoshiki et al. (2013) Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injury. Am J Respir Cell Mol Biol 48:635-46 |
| Putcha, Nirupama; Puhan, Milo A; Hansel, Nadia N et al. (2013) Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD 10:324-32 |
| Nilius, Georg; Franke, Karl-Josef; Domanski, Ulrike et al. (2013) Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol 755:27-34 |
| Lockett, Angelia D; Kimani, Samuel; Ddungu, Godfrey et al. (2013) ??-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-?. Am J Respir Cell Mol Biol 49:143-50 |
Showing the most recent 10 out of 75 publications
